One week after placement of a superior mesenteric artery (SMA) stent via brachial artery cutdown and primary repair, the patient reports hand numbness; could this be due to nerve bruising or another etiology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hand Numbness After Brachial Artery Cutdown for SMA Stenting

This is most likely median nerve injury from the brachial artery cutdown procedure itself, not nerve "bruising"—and requires urgent evaluation by a vascular surgeon to assess for potential nerve compression from hematoma, direct nerve trauma, or ischemic injury.

Primary Concern: Median Nerve Injury

The brachial artery cutdown approach carries a well-documented risk of median nerve injury, with an incidence between 0.2-1.4% in cardiac catheterization procedures 1. While your case involves SMA stenting rather than cardiac catheterization, the surgical access technique and anatomical risks are identical.

Three Mechanisms of Nerve Injury to Consider:

  1. Hematoma compression - Most common and potentially reversible if caught early
  2. Direct nerve trauma - From surgical dissection or retraction during the procedure
  3. Ischemic injury - Secondary to brachial artery complications (thrombosis, spasm, or inadequate repair)

Immediate Action Required

The patient needs emergent referral to a vascular surgeon 2. This is not a "wait and see" situation. The one-week timeframe is critical because:

  • Hematoma-related compression can progress to permanent nerve damage if not evacuated
  • Arterial complications may be evolving and threatening limb viability
  • Early intervention significantly improves functional outcomes

Clinical Assessment Priorities:

Motor function:

  • Thumb opposition (abductor pollicis brevis)
  • Index/middle finger flexion at DIP joints
  • Thenar muscle bulk

Sensory distribution:

  • Palmar surface of thumb, index, middle, and radial half of ring finger
  • Distinguish from carpal tunnel (which spares palm)

Vascular status:

  • Radial and ulnar pulses
  • Hand temperature and color
  • Capillary refill
  • Digital blood pressures if available

Signs of compartment syndrome or evolving ischemia:

  • Pain out of proportion
  • Tense forearm
  • Pain with passive finger extension

Diagnostic Workup

Immediate studies needed:

  • Duplex ultrasound of brachial artery repair site to assess patency and identify hematoma
  • Nerve conduction studies and EMG (though may be too early for denervation changes)
  • Consider hand function assessment using standardized tools

Expected Outcomes and Prognosis

Even with appropriate intervention, median nerve injuries from brachial procedures result in persistent long-term disability 1. In the study of cardiac catheterization patients:

  • Initial neurological deficits improved with time
  • All patients had persistent disability in hand function at 6-22 months follow-up
  • Dexterity and stereognosis (fine touch discrimination) remained impaired
  • This has significant medicolegal implications

Common Pitfall to Avoid

Do not dismiss this as simple "nerve bruising" or neuropraxia that will resolve spontaneously. The term "nerve bruising" minimizes what may be a serious complication requiring intervention. The median nerve provides critical hand function, and delayed recognition of compressive hematoma or ischemia can result in permanent disability including loss of thumb opposition and fine motor control.

Antiplatelet Considerations

Given the recent SMA stent placement, the patient should be on dual antiplatelet therapy (aspirin plus clopidogrel for 6 months minimum) 3. This increases bleeding risk but is essential for stent patency. Any surgical intervention for nerve decompression must balance:

  • Risk of stent thrombosis if antiplatelet agents are stopped
  • Risk of bleeding complications if continued
  • The vascular surgeon must coordinate with interventional team regarding antiplatelet management

The priority is immediate vascular surgical evaluation—do not delay for "observation" as this one-week window is already concerning for evolving complications.

References

Guideline

clinical practice guidelines for vascular access.

American Journal of Kidney Diseases, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.